Topics

Rx Pricing, Rebating Should Be Back To Business As Usual In 2020, PBMs Say

18:00 EST 7 Nov 2019 | SCRIP

Political focus of drug pricing debate has shifted away from pharmacy benefit managers, CVS Health’s Merlo suggests.

      

Related Stories

 

Original Article: Rx Pricing, Rebating Should Be Back To Business As Usual In 2020, PBMs Say

NEXT ARTICLE

More From BioPortfolio on "Rx Pricing, Rebating Should Be Back To Business As Usual In 2020, PBMs Say"

Quick Search

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...